Nuheara (ASX:NUH) receives US FDA registration for a new hearing aid

Company News

by Rachael Jones

Nuheara (ASX:NUH) has received US Food and Drug Administration establishment registration for a medical device listing of a new hearing aid, IQbuds² PRO.

The PRO, alongside IQbuds² MAX will be the second product to be derived from the recently developed IQbuds² hardware platform.

It has been designed to provide deeper levels of hearing technology sophistication, while delivering higher levels of hearing enhancement and amplification.

The PRO is expected to be launched in the US later in the calendar year.

Shares in Nuheara (ASX:NUH) are trading 4.55 per cent higher at 5 cents.
 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.